Medical and Health Services: Topic Context

Medical and health services delivered in the home setting occupy a distinct regulatory and clinical space within the broader US healthcare system. This page defines the scope of home-based medical services, explains the structural framework governing how those services are delivered, describes the clinical and social circumstances that typically generate home care episodes, and identifies the boundaries that distinguish one service category from another. Understanding these distinctions matters because eligibility criteria, reimbursement pathways, licensure requirements, and quality standards differ substantially across service types.

Definition and scope

Home-based medical and health services encompass a range of clinical, therapeutic, and supportive interventions delivered to patients in a private residence or residential-equivalent setting rather than in a hospital, clinic, or long-term care facility. The Centers for Medicare & Medicaid Services (CMS) defines home health services under 42 CFR Part 484 as skilled services — including nursing, physical therapy, occupational therapy, and speech-language pathology — provided by a certified home health agency (CHHA) to homebound individuals under a physician-established plan of care.

The scope of services broadly divides into two classification tiers:

1. Skilled (clinical) services — Require licensed or certified clinicians to deliver. Examples include skilled nursing at home, home infusion therapy, wound care at home, home ventilator care, and rehabilitative therapies such as physical therapy home care, occupational therapy home care, and speech therapy home care.
2. Non-skilled (supportive) services — Provided by paraprofessionals under supervision and include personal care, assistance with activities of daily living (ADLs), and homemaker tasks. Home health aide services occupy the boundary between these two categories, as aides may perform limited clinical tasks only under a nurse's supervision.

The distinction between skilled and non-skilled determines Medicare coverage eligibility, as documented in the Medicare home health benefit framework under Social Security Act §1861(m). Medicaid coverage frameworks, governed state-by-state under 42 CFR Part 440, extend coverage to a broader array of long-term supportive services; the Medicaid home care coverage landscape consequently varies across all 50 states and the District of Columbia.

Specialized sub-categories within this scope include hospice care at home, which operates under a separate Medicare benefit (42 CFR Part 418), palliative care at home, pediatric home health services, and home dialysis services. Telehealth in home care and remote patient monitoring constitute an expanding scope segment following CMS regulatory modifications enacted under the Consolidated Appropriations Act of 2023.

How it works

Home-based medical services follow a structured episode framework governed by federal conditions of participation (CoPs) published in 42 CFR Part 484 and enforced through CMS survey processes. The operational sequence proceeds through discrete phases:

1. Referral and eligibility determination — A physician, nurse practitioner, or clinical nurse specialist certifies homebound status and medical necessity. The homebound status definition and criteria require that leaving home demands a considerable and taxing effort, or that a condition makes it medically contraindicated.
2. Plan of care establishment — A licensed clinician, typically a registered nurse, conducts an initial assessment and collaborates with the ordering physician to establish a plan of care. CMS mandates that the plan be reviewed and recertified at least every 60 days for Medicare-certified episodes.
3. OASIS assessment — For Medicare and Medicaid patients, agencies must complete the Outcome and Assessment Information Set (OASIS-E as of January 2023) at start of care, resumption of care, recertification, and discharge. The OASIS assessment in home health drives both quality measurement and prospective payment calculations.
4. Service delivery and supervision — Clinicians deliver services according to the care plan. Home care supervision requirements under 42 CFR §484.80 mandate that a registered nurse supervise home health aide services at minimum every 14 days.
5. Documentation and billing — All visits require contemporaneous documentation. Home care documentation requirements align with both CoP standards and payer-specific billing rules under the Patient-Driven Groupings Model (PDGM), which CMS implemented in January 2020.
6. Discharge and outcomes reporting — Agencies submit OASIS discharge data, which feeds into CMS Home Health Compare quality measures and the home care quality measures public reporting infrastructure.

Quality and safety oversight also runs through accreditation bodies. The Joint Commission, the Community Health Accreditation Partner (CHAP), and the Accreditation Commission for Health Care (ACHC) each offer deemed status accreditation that substitutes for direct CMS survey under 42 CFR §488.10. Details on those standards appear in the home health agency accreditation reference.

Common scenarios

Home-based medical services arise across four primary clinical contexts:

• Post-acute transitions — Patients discharged from hospitals or skilled nursing facilities with ongoing clinical needs commonly receive post-acute home care or home care after surgery. CMS tracks 30-day readmission rates as a quality indicator specifically tied to this population.
• Chronic disease management — Patients with conditions such as congestive heart failure, chronic obstructive pulmonary disease, or diabetes may receive ongoing monitoring and skilled intervention through home care for chronic conditions. Remote patient monitoring devices, regulated as Class II medical devices under FDA 21 CFR Part 880, are increasingly integrated into these episodes.
• Pediatric and maternal care — Children with medically complex conditions and newly delivered mothers may access pediatric home health services and maternal and newborn home care, each carrying distinct scope-of-practice and staffing ratio considerations.
• End-of-life and cognitive decline — Hospice care at home, palliative programs, and home care for dementia patients address patients for whom curative intent is secondary or absent. The Medicare hospice benefit, codified in 42 CFR Part 418, requires a prognosis of 6 months or fewer if the terminal illness runs its normal course.

Decision boundaries

Distinguishing which service category applies — and which regulatory and payment framework governs — depends on three primary boundary criteria:

Skilled necessity vs. custodial need: Medicare covers home health only when skilled intervention is required and reasonable. Custodial care — help with bathing, dressing, meal preparation — is not covered under the Medicare home health benefit unless provided coincidentally within a skilled episode. Medicaid and private-pay home care arrangements cover custodial care directly.

Home health agency (HHA) vs. personal care agency (PCA): A certified HHA operates under 42 CFR Part 484 and must meet federal CoPs. A personal care agency providing only non-skilled services operates under state licensure frameworks, which differ across jurisdictions. The home care licensing by state reference documents state-level variation, which spans from comprehensive licensing regimes (California, New York) to limited or voluntary frameworks in other states.

Hospice vs. home health: A patient enrolled in the Medicare Hospice Benefit generally cannot simultaneously receive Medicare home health services for the terminal diagnosis. If curative treatment resumes, the patient must revoke hospice status. The two benefits are mutually exclusive at the diagnosis level under 42 CFR §418.24.

Hospital-at-home vs. traditional home health: Hospital-at-home programs deliver acute-level care — defined by CMS's Acute Hospital Care at Home waiver program — that meets intensity-of-service thresholds equivalent to inpatient admission. This differs from traditional home health in that physicians conduct daily visits (in-person or via telehealth) and monitoring occurs continuously, not episodically. CMS first authorized these programs under the COVID-19 public health emergency and extended authority through subsequent legislation.

Safety framing across all categories references the infection control in home care standards drawn from CDC guidelines and CoP requirements at 42 CFR §484.70, as well as fall prevention in home care protocols tied to OASIS-E functional assessment items. Medication management in home care intersects with Joint Commission National Patient Safety Goals and state pharmacy practice acts, particularly when home infusion or self-administered injectable therapies are part of the care plan.